ProQR Announces Axiomer? RNA Editing Licensing and Research Collaboration with Lilly
- Companies will collaborate?to?develop?editing?oligonucleotides?directed to?up to?five?targets?using?ProQR?s proprietary?Axiomer??RNA editing?platform
- ProQR?to receive?$50?million?consisting of upfront payment and?equity investment
- ProQR?is?eligible to?additionally?receive up to approximately?$1.25?billion?in?research,?development,?and commercialization milestones, plus royalties